- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- March 2025
- 194 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 136 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 191 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- October 2024
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- May 2024
- 287 Pages
Global
From €3327EUR$3,500USD£2,795GBP
€4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 175 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 210 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- January 2025
- 120 Pages
United States
From €2367EUR$2,490USD£1,989GBP
- Report
- February 2024
- 250 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- February 2024
- 114 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 85 Pages
North America
From €4516EUR$4,750USD£3,794GBP
- Report
- February 2024
- 90 Pages
Europe
From €4516EUR$4,750USD£3,794GBP
- Report
- October 2023
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- December 2023
- 209 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- June 2022
- 142 Pages
Global
From €3422EUR$3,600USD£2,875GBP

The Inhalational Anesthetic market is composed of inhalers and nebulisers, which are used to deliver anesthetic gases or vapors to patients. Inhalers are devices that deliver a precise dose of anesthetic gas or vapor to the patient's lungs. Nebulisers are devices that convert anesthetic gas or vapor into a mist that can be inhaled by the patient. Both inhalers and nebulisers are used in a variety of medical settings, including operating rooms, intensive care units, and emergency rooms.
Inhalers and nebulisers are used to provide a safe and effective delivery of anesthetic gases or vapors to patients. They are designed to minimize the risk of anesthetic overdose and to ensure that the patient receives the correct dose of anesthetic. Inhalers and nebulisers are also used to reduce the risk of anesthetic-related side effects, such as nausea, vomiting, and dizziness.
The Inhalational Anesthetic market is highly competitive, with a number of companies offering a variety of inhalers and nebulisers. Some of the major players in the market include Baxter, Becton Dickinson, Covidien, GE Healthcare, and Smiths Medical. Show Less Read more